Extracellular measurement of oxygen consumption and acid production is a simple and powerful way to monitor rates of respiration and glycolysis 1 . Both mitochondrial (respiration) and non-mitochondrial (other redox) reactions consume oxygen, but these reactions can be easily distinguished by chemical inhibition of mitochondrial respiration. However, while mitochondrial oxygen consumption is an unambiguous and direct measurement of respiration rate 2 , the same is not true for extracellular acid production and its relationship to glycolytic rate [3][4] [5] [6] . Extracellular acid produced by cells is derived from both lactate, produced by anaerobic glycolysis, and CO 2 , produced in the citric acid cycle during respiration. For glycolysis, the conversion of glucose to lactate -+ H + and the export of products into the assay medium is the source of glycolytic acidification. For respiration, the export of CO 2 , hydration to H 2 CO 3 and dissociation to HCO 3 -+ H + is the source of respiratory acidification. The proportions of glycolytic and respiratory acidification depend on the experimental conditions, including cell type and substrate(s) provided, and can range from nearly 100% glycolytic acidification to nearly 100% respiratory acidification 6
Introduction
The overall goal of this method is to accurately measure the glycolytic rate of cells using extracellular flux analysis. Quantitative measurement of glycolytic rate using extracellular acidification is the desired endpoint of many experiments. However, the total rate of extracellular acidification is the sum of two components: respiratory acidification, in the form of CO 2 (which hydrates to H 2 CO 3 then dissociates to HCO 3 -+ H + ), and glycolytic acidification, in the form of lactate -+ H + .
The contributions of CO 2 to total extracellular acidification have until recently been considered negligible in the measurement platform used here, the XF24 analyzer 7 . However, it is clear in multiple other systems that CO 2 can be a major contributor to extracellular acidification [4] [5] . Multiple papers acknowledge this contribution, but do not attempt direct quantitation of CO 2 -derived acid 3, 8, 9 . We recently demonstrated quantitatively that CO 2 production is a significant source of extracellular acidification in this system 6 . Moreover, though there are multiple metabolic pathways that generate CO 2 from glucose catabolism, those carried out by matrix dehydrogenases in the citric acid cycle are the overwhelming contributors and all other sources generate amounts of CO 2 that are within experimental error 6 . Without correcting for CO 2 production, extracellular acidification is therefore an ambiguous indicator of glycolytic rate and cannot be used quantitatively. Our previous publication highlights several instances where respiratory CO 2 comprises the bulk of the total acidification signal, even in cells generally believed to primarily use glycolysis 6 . Additionally, the respiratory CO 2 contribution to total acidification varies widely during the course of common metabolic profiling experiments, demonstrating that correct comparison of the glycolytic rate during different parts of an experiment requires correction for CO 2 .
To measure the glycolytic rate of cells using the rate of extracellular acidification, it is necessary to convert pH changes to changes in total H + generated, and to subtract the extracellular acidification caused by CO 2 released during operation of the citric acid cycle. Here, we describe a straightforward method for measuring extracellular proton production rate (from extracellular changes in pH and the calibrated buffering power of the assay medium) and CO 2 production (from extracellular changes in O 2 concentration), and demonstrate how to calculate glycolytic rate using these measurements.
PPR resp = (10 In this way, rates of respiration and glycolysis, as well as their associated ATP production rates, can be quantitatively determined from straightforward measurements (oxygen consumption, extracellular acidification, buffering capacity) and import or calculation of other required values (H + /O 2 , P/O, and the equilibrium constant K 1 ) 6 . The experiment described here expands on standard techniques for using the Extracellular Flux Analyzer such as Seahorse XF24 10, 11 ; for other extracellular flux measurement formats (e.g., XF e 96, or XFp), all volumes below should be scaled appropriately.
The buffering power of the assay medium can be measured by construction of a standard curve either directly in the extracellular flux platform or separately using a calibrated pH probe. Here, three options for measuring buffering by the extracellular flux assay medium are given, including using all injection ports of the extracellular flux analyzer with cell-free sample wells, or using only the last injection port in cell-containing wells (section 1) or by using an external pH measurement (section 2). See the attached spreadsheet for the full calculations of example data.
To measure buffering power using the pH-detecting capability of the extracellular flux instrument, it is safest to use cell-free wells to minimize signal variation. However, within the error, no statistical difference exists between cell-free and cell-containing wells when performing this measurement (data not shown). NOTE: The variation described in step 1.7 carries the advantage of accounting for any potential changes to buffering conferred by added compounds or by the presence of cells, with the disadvantage of noisier signal. However, as stated above, no significant differences were found in the calculated buffering power between the cell-free design shown in Table 1 and the post-experiment design in Table 2 under the experimental conditions described here. ]. The slope of this standard curve therefore represents the buffering power of the assay medium under test in pH/nmol H + in 7 µl, or mpH/pmol H + in 7 µl. We recommend increasing medium buffering power or decreasing cell density for samples that exceed a 0.2 pH unit change during the measurement time. The measurement time may also be decreased, but this may shorten the steady state acidification rate and introduce error into the rate calculation. 2. Prepare dilutions of the HCl standard in the medium to be assayed as in Table 1 for the number of technical replicates being carried out in one plate, plus one to allow for pipetting error; e.g., for four technical replicates of the port A injection, prepare a stock of (1.1 µl x 5) 0.1 M HCl in (48.9 µl x 5) assay medium. 3. Distribute 50 µl into each Port A of the measurement probe cartridge. Repeat this procedure for remaining ports B, C, and D. 4. Run an extracellular flux assay 10 with a standard calibration cycle, followed by two cycles of [2 min mix, 1 min wait, and 5 min measurement]
for each of the four port additions (see Figure 2 ). 1. Program the experiment above in the instrument software according to software instructions. Load the prepared cartridge into the machine and perform calibration according to software instructions. 2. When prompted by the program, remove the calibrant-containing plate and insert the plate containing assay medium in each well into the instrument; continue the program.
5. Using the average of 8-10 data points obtained at steady state (typically the last 8-10 points) from before and after each port addition, calculate the (cumulative) difference in pH (∆pH) caused by each injection of standard acid. 6. Plot ∆pH against nmol H + contained in the 7 µl volume trapped by the measurement probe. The linear slope is the buffering power (BP) in mpH/pmol H + . 7. Alternatively to steps 1.2-1.3, carry out the ∆pH measurements following an assay in which Ports A, B, and C are used for conducting an experiment, followed by an HCl injection in Port D. As in Table 2 , four technical replicates are used to generate each point of a 5-point standard curve in the 20 experimental wells (excluding the four background temperature correction wells) of the extracellular flux assay plate. 
Measuring Buffering Power Using an External pH Meter
NOTE: To measure the buffering power of a medium using an external pH probe, calibrate the probe at 37 °C and maintain this temperature for all reagents during the experiment.
1. Prepare 0.1 M standard HCl in water using HCl concentrate according to manufacturer instructions. 2. Warm pH probe, pH standards, the assay medium whose buffering power is to be measured, and 0.1 M HCl to 37 °C in a water bath. 3. Calibrate pH probe at 37 °C according to manufacturer instructions. Maintain all reagents at 37 °C throughout the assay by using a heat plate or water bath. 4. Aliquot 10 ml of the assay medium into a small beaker or conical tube. Monitor pH continuously using an immersed pH probe. 5. Add 0.1 M HCl to the assay medium in 10-20 µl aliquots.
1. Ensure mixing by using a stir bar or by manually swirling the container after each acid addition. 2. Allow a few seconds for the pH measurement to stabilize, then record the pH after each addition. 3. As demonstrated in Table 3 , make a sufficient number of additions to ensure accurate slope calculation and to cover the pH range expected during the experiment.
Copyright Table 1, Table 2 or (here) as in Table 3 . The slope of the linear curve fit gives the buffering power (pH/nmol H + in 7 µl). Each point represents mean ± SEM of n = 9 technical replicates. 8. Alternatively, use the same experiments in Methods 1 or 2 to calculate the Buffering Capacity (BC) value used by the instrument software to automatically calculate PPR during data collection. NOTE: The instrument user manual 12 (page 107) provides detailed information about calculating and using buffering capacity, where BC is NOTE: If known prior to performing the assay, the buffering capacity can be entered directly into the instrument software during experimental setup. 9. Apply this procedure and the calculations used above to most conventional buffer systems, as described in previous publication 1. Culture mouse C2C12 myoblasts 13 at 37 °C under 95% air/5% CO 2 in Dulbecco's modified Eagle medium (DMEM) with 11.1 mM glucose, 2 mM glutamine, 10% v/v fetal bovine serum (FBS), 100 U/ml penicillin and 100 µg/ml streptomycin. 2. 24 hr prior to assay, plate/seed cells in 100 µl of the same culture medium at 20,000 cells/well in a 24-well polystyrene extracellular flux assay plate (see Materials and Methods) with no additional coating. 3. Dilute oligomycin, FCCP, and rotenone plus myxothiazol, and HCl (optional) to 10x final concentration in Krebs Ringer Phosphate HEPES (KRPH) assay medium (2 mM HEPES, 136 mM NaCl, 2 mM NaH 2 PO 4 , 3.7 mM KCl, 1 mM MgCl 2 , 1.5 mM CaCl 2 , 0.1% w/v fatty-acid-free bovine serum albumin, pH 7.4 at 37 °C). 4. Cell preparation 1. 30 min prior to the assay, wash adherent cells three times by aspirating to gently remove the medium from the well and then slowly adding 500 µl KRPH. 2. Incubate cells after the third wash step at 37 °C under air (not under 5% CO 2 , which will alter the pH of this bicarbonate-free medium). 3. At assay start, replace KRPH in wells with 500 µl fresh KRPH containing 500 U/ml carbonic anhydrase and either glucose (10 mM) or medium only, with no additional substrate.
5. Loading the sensor cartridge 1. Pipet 50 µl aliquots of each 10x compound prepared in Step 3.3 into cartridge ports of an extracellular flux sensor cartridge as follows (final concentrations in assay well given): Port A: 2 µg/ml oligomycin, Port B: 0.5 µM FCCP, Port C: 1 µM rotenone, 1 µM myxothiazol, Port D: HCl (if performing an in-assay acid calibration as described above and in Table 2 ). NOTE: for the purpose of complete respiratory chain inhibition described here, 1 µM myxothiazol may be used interchangeably with 1 µM antimycin A.
6. Extracellular flux assay: 1. Perform a standard extracellular flux assay for determining respiratory control as described in NOTE: The data in Table 5 were collected over two assay cycles of 2 min mix, 1 min wait, and 5 min measure for each segment, with three assay cycles occurring after the Port D addition of different amounts of HCl (for calibration of buffering power as in Table 2 ). 
Measuring End-point Lactate Concentration
NOTE: To validate the indirect assay described here in some different system, end point lactate concentration at the end of an extracellular flux experiment can be determined directly in a conventional 96-well plate by measuring the initial velocity (over 2 min) of reduction of NAD + → NADH catalyzed by lactate dehydrogenase, described in detail in our prior publication 6 . For the data presented in Representative Results, the end point lactate concentration in glucose-containing assay wells was ~40 μM.
1. Prepare 2x hydrazine medium: 1 M Tris, 20 mM EDTA, 400 mM hydrazine, pH 9.8 at 22 °C). Immediately before assay start, add NAD + to 4 mM and lactate dehydrogenase (LDH) to 40 U/ml. Final assay medium composition (1x): 500 mM Tris, 10 mM EDTA, 200 mM hydrazine, 2 mM NAD + Representative Results Figure 2 shows the raw data for a typical experiment. The last 10 measurement points from the point-to-point recording of both OCR and pH (shaded vertical bars) were used for the calculations. Initial concerns that the average value (middle point measurement) of each assay cycle would not provide sufficient resolution of rate for an accurate calculation, particularly as there appeared to be a slight lag between port addition and steady state acidification rate, were not borne out, as this does not appear to contribute significantly to calculation error (not shown). Alternatively, if the correct buffering capacity is entered during experimental setup, PPR can be read directly from the instrument data collection readout by displaying the PPR output in the instrument software or in the PC-compatible format available as one of the data output settings. Table 5 , containing 10 mM glucose at assay start. Port D had different HCl concentrations for calibration of buffering power (not shown in these averaged traces). Data from previous publication 6 . Each point represents mean ± SEM of n = 8 biological replicates. Please click here to view a larger version of this figure.
Data analysis of representative results
Using the spreadsheet shown in Table 6 and provided as an attachment, data values from individual wells may be entered in the columns shown with yellow headers. All six columns to the right are calculated from these entries. The example in Table 6 shows the calculations of PPR resp and PPR glyc using ECAR and OCR data from individual wells for the native conditions with or without added glucose, prior to Port Figure 3 shows the graphical output of data calculated as in Table 6 for native rates of glycolytic and respiratory acidification, rates following oligomycin addition (Port A), and rates following FCCP addition (Port B). These data clearly demonstrate how the proportions of respiratory and glycolytic acidification change with choice of substrate (glucose vs. control (ctl) with none added) and with mitochondrial status (native function vs. pharmacologically altered function). 
Contributions of glycolysis and respiration to PPR after correction

Discussion
Extracellular acidification is an easily measured indication of cellular metabolic rate. To properly determine the rate of cellular glycolysis (as defined by lactate production) it is critical to know the buffering power of the assay medium, and to convert the extracellular flux measurements of oxygen consumption and acidification to proton production rates. By performing this calculation, the acidification resulting from CO 2 released in the citric acid cycle can be subtracted, leaving the acidification that results from lactate production.
The multiple different ways given here to measure buffering power for this correction carry different advantages and disadvantages. External measurement using a pH probe is highly accurate and reproducible, but may not reflect small differences in pH detection introduced by the The CO 2 correction to ECAR allows for the first time the unambiguous and quantitative calculation of glycolytic rate, and reveals variation in respiratory and glycolytic contribution to total ECAR during the course of an experiment. Using Equation 5 and the measurements of OCR, ECAR, and buffering power, glycolytic rate can be calculated using the simple spreadsheet provided ( Table 6 ). This rate can be verified by posthoc lactate measurement if desired 6 . In cells where the pentose phosphate pathway is highly active, the use of pathway inhibitors such as 6-aminonicotinamide may be useful to isolate glycolytic rate. Calculation of the contributions of both CO 2 -and lactate-derived H + from the total measured Extra Cellular Acidification Rate and Oxygen Consumption Rate is an invaluable tool for using extracellular flux data to make powerful and quantitative statements about metabolic activity.
Using the procedures described here, including various modifications for measuring buffering power, and optimizing the extracellular flux experiment for the cells under investigation and data desired, the rate of glycolysis in intact cells can be quantified under a wide range of experimental conditions. This method is limited to cells that can grow in adherent culture on (or cells or organelles that can be adhered to) a polystyrene surface. It is most reliable when cultured cells are homogenous and confluent, though useful data may still be obtained over a range of these conditions. The calculations require some knowledge of the metabolism of the cells, as max H + /O 2 ranges from 0.65 to 1.0 for full oxidation of different substrates and more for partial oxidation 6 , however, if the cells are known to oxidize glucose, a value of 1.0 can be assumed.
Though relevant to all metabolic characterization, this method may be particularly helpful when used in systems in which a shift between respiratory and glycolytic metabolism to maintain cellular ATP supply is a critical phenotype, including the characterization of stem cells and tumor-derived cancer cells. Understanding metabolic control alterations in these and other contexts will allow a greater degree of sophistication and accuracy in the experimental design and analysis of these cell types.
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